The Outcome of Six-month Clinical Trial with Eucatax Paclitaxel Eluting Stent Compared With Eucastsflex Bare Metal Stent in Patients Undergoing De Novo Coronary Stenting

Mohammad Ali Ostovan; M  Rezaie; Javad  Kojuri

International Cardiovascular Research Journal

The Official Annually Journal of Cardiovascular Research Center, Shiraz University of Medical Sciences

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Boards & Committees Indexing and Listing Sources Journal Metrics Publication Ethics and Publication Malpractice Statement Reviewer and AE Registration Form Support Contact Us

APC

Authors Guide Submit Manuscript

The Outcome of Six-month Clinical Trial with Eucatax Paclitaxel Eluting Stent Compared With Eucastsflex Bare Metal Stent in Patients Undergoing De Novo Coronary Stenting

Author(s):

Mohammad Ali Ostovan¹,

M Rezaie^1,*,

Javad Kojuri¹

1Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

International Cardiovascular Research Journal:Vol. 4, issue 2; e65013

Published online:Jun 30, 2010

Article type:Research Article

Received:Dec 17, 2017

Accepted:Jun 30, 2010

How to Cite:Ostovan MA, Rezaie M, Kojuri J. The Outcome of Six-month Clinical Trial with Eucatax Paclitaxel Eluting Stent Compared With Eucastsflex Bare Metal Stent in Patients Undergoing De Novo Coronary Stenting. Int Cardiovasc Res J. 2010;4(2):e65013. doi:

Abstract

Background: Superiority of paclitaxel-eluting stents over bare metal stents in angiographic and clinical outcomes
have been shown in many trials . Eucatax stents is a newly developed paclitaxel eluting stent using biodegradable
polymer matrix. To our knowledge there have been no studies directly comparing Eucatax paclitaxel
eluting stents with EucaSTSflex bare metal stents. The aim of this study is to evaluate short-term benefits of
Eucatax in comparison with EucaSTSflex in patients undergoing denovo coronary stenting.
Methods: A retrospective comparison of Eucatax versus EucaSTSflex was conducted among 89 consecutive
patients (44 Eucatax, 45 EucaSTSflex) in Kowsar heart institute, with at least one successfully deployed stent in
de novo lesions over a 6-month period. Outcomes included death ,nonfatal MI, CABG, late stent thrombosis
at six month, as well as functional evidence of ischemia evaluated by exercise treadmill test(ETT) or cardiac
scan( SPECT).
Results: From April to July 2008, a total of 89 patients (44 Eucatax, 45 EucaSTSflex) were evaluated after PCI
for de novo coronary lesions.
After six month follow up no difference was observed in term of death ,MI,CABG and late stent thrombosis
between Eucatax compared with EucaSTSflex. Also a non-statistically significant lower rate of positive ETT (or
SPECT) was found in Eucatax group after six month.
Conclusion: Paclitaxel eluting stents(Eucatax)are not superior to bare metal stents(EucaSTSflex) in regard to
short-term clinical outcome.

Keywords

Fulltext

The full text is available in PDF.

References

1.
The references are available in PDF.

Safety of enoxaparin versus unfractioned heparin in patients undergoing percutaneous coronary intervention using drug eluting stents: A pilot study

Mohammad Javad Zibaeenezhad,

H Kamfiroozi,

Kamran Aghasadeghi

Zibaeenezhad MJ, Kamfiroozi H, Aghasadeghi K. Safety of enoxaparin versus unfractioned heparin in patients undergoing percutaneous coronary intervention using drug eluting stents: A pilot study. Int Cardiovasc Res J. 2018;1(3):e79524. doi:

8

Feb

2026

Paclitaxel- and Sirolimus-Coated Drug-Coated Balloons versus Drug-Eluting Stents in Acute Myocardial Infarction: A Comprehensive Systematic Review and Meta-Analysis

Zhengmin Zhang,

Gang Yu,

Rong Guo

Zhang Z, Yu G, Guo R. Paclitaxel- and Sirolimus-Coated Drug-Coated Balloons versus Drug-Eluting Stents in Acute Myocardial Infarction: A Comprehensive Systematic Review and Meta-Analysis. Iran J Pharm Res. 2025;24(1):e164739. doi: https://doi.org/10.5812/ijpr-164739

16

Dec

2021

One-Year Outcomes of Two Different Paclitaxel-Eluting Stents (Zilver PTX and Eluvia) for Trans-Atlantic Inter-Society Consensus Document (TASC) C/D Obstructive Femoropopliteal Lesions

Lyo Min Kwon,

Saebeom Hur,

Hwan Jun Jae,

Seung-Kee Min,

Sang-Il Min,

Sanghyun Ahn

,et al.

Kwon LM, Hur S, Jae HJ, Min S, Min S, et al. One-Year Outcomes of Two Different Paclitaxel-Eluting Stents (Zilver PTX and Eluvia) for Trans-Atlantic Inter-Society Consensus Document (TASC) C/D Obstructive Femoropopliteal Lesions. I J Radiol. 2022;19(1):e111918. doi: https://doi.org/10.5812/iranjradiol.111918

20

Dec

2017

Comparison of Solitaire-FR and Trevo-ProVue Thrombectomy in Patients with Anterior Circulation Large Artery Occlusion

Jin Woo Kim,

Byung Hoon Lee,

Yoon Joon Hwang

Kim JW, Lee BH, Hwang YJ. Comparison of Solitaire-FR and Trevo-ProVue Thrombectomy in Patients with Anterior Circulation Large Artery Occlusion. I J Radiol. 2018;15(1):e14404. doi: https://doi.org/10.5812/iranjradiol.14404

30

Sep

2007

Percutaneous transluminal coronary angioplasty and use of drug-eluting stent in shiraz catheterization centers during 2006

Javad Kojuri,

AR Vosoughi,

Shahdad Khosropanah

Kojuri J, Vosoughi A, Khosropanah S. Percutaneous transluminal coronary angioplasty and use of drug-eluting stent in shiraz catheterization centers during 2006. Int Cardiovasc Res J. 2009;1(3):e79525. doi:

Import into EndNote Import into BibTex

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 2 weeks ago
Scopus by Title: 0
Last Update: 2 weeks ago
Scopus by Title (Ref): 0
Last Update: 2 weeks ago
CrossRef: 0
Last Update: 11 hours ago

Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

Mohammad Ali Ostovan:[PubMed][Scholar]
M Rezaie:[PubMed][Scholar]
Javad Kojuri:[PubMed][Scholar]

The Official Annually Journal of Cardiovascular Research Center, Shiraz University of Medical Sciences

Outlines

The Outcome of Six-month Clinical Trial with Eucatax Paclitaxel Eluting Stent Compared With Eucastsflex Bare Metal Stent in Patients Undergoing De Novo Coronary Stenting

Abstract

Fulltext

References

Similar Articles

Safety of enoxaparin versus unfractioned heparin in patients undergoing percutaneous coronary intervention using drug eluting stents: A pilot study

Paclitaxel- and Sirolimus-Coated Drug-Coated Balloons versus Drug-Eluting Stents in Acute Myocardial Infarction: A Comprehensive Systematic Review and Meta-Analysis

One-Year Outcomes of Two Different Paclitaxel-Eluting Stents (Zilver PTX and Eluvia) for Trans-Atlantic Inter-Society Consensus Document (TASC) C/D Obstructive Femoropopliteal Lesions

Comparison of Solitaire-FR and Trevo-ProVue Thrombectomy in Patients with Anterior Circulation Large Artery Occlusion

Percutaneous transluminal coronary angioplasty and use of drug-eluting stent in shiraz catheterization centers during 2006

Last Update: 2 weeks ago

Last Update: 2 weeks ago

Last Update: 2 weeks ago

Last Update: 11 hours ago